CD4+ T cell levels are decreased during active CMV infection in kidney transplant recipients

FEMS Immunology and Medical Microbiology

Volumn 34, Issue 1, 2002, Pages 17-22

  Essa, Sahar ^a   Pacsa, Alexander S ^a   Raghupathy, Raj ^a   Al Attiyah, Raja'a ^a   El Shazly, Amany ^a   Said, Tareq ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

Author keywords

CD4+; Cytomegalovirus; Transplant

Indexed keywords

CD15 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; DIPEPTIDYL PEPTIDASE IV;

ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; RECIPIENT; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIGENS, CD3; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOPHENOTYPING; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 0037031554     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(02)00324-3     Document Type: Article

References (22)

1. Tolkoff-Rubin N.E., Rubin R.H. Viral infection in the renal transplant recipients. Curr. Opin. Nephrol. Hyperten. 1:1992;243-248.
2. Lautenschlager I., Salmela K., Häyry P. Does CMV infection affect the outcome of renal allografts? Transplant. Proc. 24:1992;283-284.
3. Einsele H., Ehninger G., Steidle M., Fischer I., Bihler S., Gerneth F., Vallbracht A., Schmidt H., Waller H.D., Muller C.A. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood. 82:1993;1672-1678.
4. Gerard L., Leport C., Flandre P., Houhou N., Salmon-Ceron D., Pepin J.M., Mandet C., Brun-Vezinet F., Vilde J.L. Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 24:1997;836-840.
5. Williams P.L., Currier J.S., Swindells S. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections. AIDS. 13:1999;1035-1044.
6. Lu Y., Bigger J.E., Thomas C.A., Atherton S.S. Adaptive transfer of murine cytomegalovirus-immune lymph node cells prevents retinitis in T-cell-depleted mice. Invest. Ophthalmol. Vis. Sci. 38:1997;301-310.
7. Podlech J., Holtappels R., Wirtz N., Steffens H.P., Reddehase M.J. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. J. Gen. Virol. 79:1998;2099-2104.
8. Riddell S.R., Greenberg P.D. T cell therapy of human CMV and EBV infections in immunocompromised hosts. Rev. Med. Virol. 7:1997;181-192.
9. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., Riddell S.R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1995;1038-1044.
10. Waldrop S.L., Pitcher C.J., Peterson D.M., Maino V.C., Picker L.J. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99:1997;1739-1750.
11. Ljungman P., Plotkin S.A. Workshop on CMV disease: definitions, clinical severity scores, and new syndromes. Scand. J. Infect. Dis. 99:1995;S87-S89.
12. Borzini P., Aniasi A., DeGiacomo M., Bersani L., Sirchia G. Detection of human mononuclear cell subsets by complement fixation monoclonal antibodies: evaluation of manual procedures. J. Clin. Immunol. 2:1982;95S-102S.
13. Beik A.I., Morris A.G., Higgins R.M., Lam F.T. Serial flow cytometric analysis of T-cell surface markers can be useful in differential diagnosis of renal allograft dysfunction. Clin. Transplant. 12:1998;24-29.
14. Belles-Isles M., Houde I., Lachance J.G., Noel R., Kingma I., Roy R. Monitoring of cytomegalovirus infections by the CD8+CD38+ T-cell subsets in kidney transplant recipients. Transplantation. 65:1998;279-282.
15. van der Berg A.P., van Son W.J., Janssen R.A., Borns N.H., Heyn A.A., Scholten-Sampson A., Postma S., van der Giessen M., Tegzess A.M., de Leij L.H. Recovery of cytomegalovirus infection is associated with activation of peripheral blood lymphocytes. J. Infect. Dis. 166:1992;1228-1235.
16. Michelson, S. (1998) Mechanisms of immunosuppression by human cytomegalovirus. In: CMV-Related Immunopathology, Monogr. Virol. (Scholz, M., Ed.), pp. 12-28. Karger, Basel.
17. Barnes P.D., Grundy J.E. Down-regulation of the class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus. J. Gen. Virol. 73:1992;2395-2403.
18. Warren E.H., Greenberg P.D., Riddell S.R. Cytotoxic T-lymphocytes-defined human minor histocompatibility antigens with a restricted tissue distribution. Blood. 91:1998;2197-2207.
19. Beck S., Barrell B.G. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature. 331:1988;269-272.
20. Chee M.S., Bankier A.T., Beck S., Bohni R., Brown C.M., Cerny R., Horsnell T., Hutchinson C.A., Kouzarides T., Martignetti J.A., Preddie E., Satchwell S.C., Tomlinson P., Weston K.M., Barrell B.G. Analysis of protein-coding content of the sequence of human cytomegalovirus strain AD 169. Curr. Top. Microbiol. Immunol. 154:1990;125-169.
21. Reyburn H.T., Mandelboim O., Vales-Gomez M., Davis D.M., Pazmany L., Strominger J.L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature. 386:1997;514-517.
22. Essa S., Raghupathy R., Pacsa A., El-Shazly A., Tareq S., Azizieh F. Inhibition of Th1-type cytokines in kidney transplant recipients with active CMV infection. J. Med. Virol. 60:2000;223-229.